MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 05.11.2025
Charles River Laboratories International Anteile 2011-2025 | CRL
Anteile Jährlich Charles River Laboratories International
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.4 M | 51.2 M | 50.8 M | 50.3 M | 49.6 M | 49.7 M | 49 M | 48.6 M | 47 M | 47.6 M | 47.6 M | 48.5 M | 48.4 M | 50.8 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 51.4 M | 47 M | 49.3 M |
Anteile Vierteljährlich Charles River Laboratories International
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49.2 M | 49.1 M | 50.7 M | 51.1 M | 51.4 M | 51.6 M | 51.4 M | 51.3 M | 51.3 M | 51.2 M | 51.1 M | 50.9 M | 50.9 M | 50.8 M | 50.6 M | 50.5 M | 50.4 M | 50.3 M | 50 M | 49.8 M | 49.7 M | 49.6 M | 49.2 M | 48.9 M | 48.8 M | 48.8 M | 48.5 M | 48.2 M | 48.3 M | 48.2 M | 47.8 M | 47.4 M | 47.5 M | 47.6 M | 47.5 M | 47.4 M | 47.2 M | 47.1 M | 46.6 M | 46.7 M | 46.3 M | 46.7 M | 46.8 M | 47.3 M | 46 M | 46.9 M | 47.1 M | 47.6 M | 47.9 M | 48.3 M | 47.7 M | 48.9 B | 47.6 M | 48 M | 48.3 M | 48.9 M | 50.1 M | 51 M | 53.9 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 48.9 B | 46 M | 877 M |
Anteile anderer Aktien in der Diagnostik & Forschung
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
31.2 M | $ 16.64 | -1.95 % | $ 99.4 M |  Israel |
 |
Exact Sciences Corporation
EXAS
|
185 M | $ 101.5 | - | $ 18.8 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 16.66 | 5.75 % | $ 179 M |  China |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
1.27 M | $ 1.57 | -3.4 % | $ 2 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 38.42 | -0.54 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
DarioHealth Corp.
DRIO
|
28.4 M | $ 11.98 | 0.76 % | $ 340 M | Israel |
 |
DexCom
DXCM
|
386 M | $ 65.76 | -1.79 % | $ 25.4 B | USA |
 |
Danaher Corporation
DHR
|
731 M | $ 226.02 | -0.21 % | $ 165 B | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 26.95 | -0.7 % | $ 815 M | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
53.8 M | $ 19.75 | -3.94 % | $ 1.06 B | USA |
 |
Celcuity
CELC
|
39.4 M | $ 103.17 | -1.98 % | $ 4.07 B | USA |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
31.9 K | $ 3.37 | -5.86 % | $ 107 K | USA |
 |
Co-Diagnostics
CODX
|
29.3 M | $ 0.31 | -9.72 % | $ 9.1 M | USA |
 |
IQVIA Holdings
IQV
|
181 M | $ 222.26 | 0.02 % | $ 40.3 B | USA |
 |
Guardant Health
GH
|
123 M | $ 103.49 | 1.39 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
117 M | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
159 M | $ 134.29 | -0.43 % | $ 21.4 B | USA |
 |
Quotient Limited
QTNT
|
91.6 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 183.1 | 0.32 % | $ 20.3 B | USA |
|
Biodesix
BDSX
|
130 M | $ 7.64 | -2.74 % | $ 991 M | USA |
 |
Mettler-Toledo International
MTD
|
21.2 M | $ 1 407.75 | 0.99 % | $ 29.9 B | Schweiz |
 |
Myriad Genetics
MYGN
|
90.6 M | $ 6.97 | -3.33 % | $ 631 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
83.9 M | $ 260.62 | -1.35 % | $ 21.9 B | USA |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 182.8 | -2.03 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
82.5 M | $ 699.0 | -0.74 % | $ 57.6 B | USA |
 |
NeoGenomics
NEO
|
127 M | $ 12.06 | 1.73 % | $ 1.53 B | USA |
 |
Neogen Corporation
NEOG
|
217 M | $ 6.79 | -1.09 % | $ 1.47 B | USA |
 |
Lantheus Holdings
LNTH
|
69.2 M | $ 67.14 | 0.78 % | $ 4.65 B | USA |
 |
Agilent Technologies
A
|
304 M | $ 140.44 | 0.56 % | $ 42.7 B | USA |
 |
Biomerica
BMRA
|
2.3 M | $ 2.43 | -5.89 % | $ 5.58 M | USA |
 |
Bioventus
BVS
|
62.6 M | $ 7.53 | -0.26 % | $ 472 M | USA |
 |
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M | Israel |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Pacific Biosciences of California
PACB
|
254 M | $ 2.11 | -0.47 % | $ 535 M | USA |